As the combination of PD-1/PD-L1 inhibitors becomes a trend in exploring treatments for solid tumors, the potential anti-tumor effects and good safety profile of BPI-371153 may contribute to the development of more effective and safer combination therapies.
PD-1/PD-L1抑制剂与BPI-371153联合治疗肿瘤的前景
本文探讨PD-1/PD-L1抑制剂与BPI-371153联合治疗实体瘤的潜力，分析其抗肿瘤效果与安全性，为开发更有效、更安全的联合疗法提供依据。
与梅斯小智对话
